---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-036629"
form_type: "8-K"
ticker: "SIGA"
cik: "0001010086"
company_name: "SIGA TECHNOLOGIES INC"
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T22:45:21.593066+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# U.S. Government exercises ~$138M procurement options for oral and IV TPOXX from SIGA

## Summary
- BARDA contract options exercised: ~$113M oral TPOXX (delivery in 2023) and ~$25M IV TPOXX (delivery starts 2024).
- Orders follow 2022 deliveries to 13 international customers and U.S. DoD; CEO notes growing global demand for orthopoxvirus preparedness.
- Oral TPOXX fully deliverable in 2023; IV TPOXX delivery under prior order to be completed before starting this new IV order.
- Contract supported by HHS/ASPR/BARDA and Strategic National Stockpile under Contract No. 75A50118C00019.

## SEC filing metadata
- accession: 0001140361-23-036629
- form_type: 8-K
- ticker: SIGA
- cik: 0001010086
- company_name: SIGA TECHNOLOGIES INC
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1010086/000114036123036629/0001140361-23-036629-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1010086/000114036123036629/brhs20056591_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-036629
- JSON: https://secwatch.observer/filing/0001140361-23-036629.json
- Plain text: https://secwatch.observer/filing/0001140361-23-036629.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.